| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.56 | 0.005 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.52 | 0.009 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.5 | 0.002 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.5 | 0.008 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.48 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.47 | 0.02 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.47 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.41 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.39 | 0.09 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.39 | 0.1 |